Consistent with previous reports, biopsies with high metabolic activity showed activated AR and glucocorticoid receptor signaling but suppressed neuroendocrine prostate cancer signature (Figure 5C and Supplemental Figure 4B) (30, 31). This evidence concerns the gene NR3C1 and prostate carcinoma.